Results 281 to 290 of about 407,038 (348)
Conservation assessment of human splice site annotation based on a 470-genome alignment. [PDF]
Minkin I, Salzberg SL.
europepmc +1 more source
Annexin A3 (ANXA3) plays an endogenous protective role in endothelial dysfunction in sepsis by stabilizing the actin cytoskeleton, modulating cell permeability, and inhibiting pATF2/CD62E inflammatory signaling. Abstract Increased endothelial permeability and a dysregulated inflammatory response play key roles in organ damage in sepsis.
Manyu Xing+4 more
wiley +1 more source
ELLIPSIS: robust quantification of splicing in scRNA-seq. [PDF]
Van Hecke M+5 more
europepmc +1 more source
RNA modification is crucial in fibrosis diseases, but the role of m1A modification remains elusive. This study reveals that ALKBH3, an m1A demethylase, drives skin fibrosis by reshaping m6A RNA modification and stabilizing COL1A1 and FN1 mRNAs through METTL3, uncovering a crosstalk between m1A and m6A methylation in pathological events.
Liying Tu+9 more
wiley +1 more source
Gene Editing for Duchenne Muscular Dystrophy: From Experimental Models to Emerging Therapies. [PDF]
Haque US, Yokota T.
europepmc +1 more source
Magnetic field‐guided MNP@ATR‐ASO nanocomplexes facilitate the targeted delivery of ASOs to ganglion cells or photoreceptors within retinal explants, thereby enhancing the efficacy of ASOs in correcting pre‐mRNA splicing abnormalities. Furthermore, the nanocomplexes improve ASO penetration and delivery in human retinal and inner ear organoid models ...
Xiuhong Ye+13 more
wiley +1 more source
Rubinstein-Taybi syndrome with ganglioneuroblastoma: a case report and literature review. [PDF]
Zhou J+7 more
europepmc +1 more source
PRMT1 drives carboplatin resistance and tumor progression in head and neck squamous cell carcinoma (HNSCC) through a novel, methyltransferase‐independent mechanism. It recruits the SWI/SNF complex to activate IGF2BP2, promoting tumor growth and carboplatin resistance. PBX2 upregulates PRMT1, reinforcing this pathway. This study uncovers a non‐catalytic
Shixian Liu+22 more
wiley +1 more source
Analysis of Exon Skipping Applicability for Dysferlinopathies. [PDF]
Leckie J+3 more
europepmc +1 more source